Speech-Language Pathologists in Tierra Amarilla, NM Accepting Medicare
3 Speech-Language Pathologists found. Showing 1 - 3
 Mrs. Deborah Jan Wilson, M.ED, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: State Rd 531, Chama Valley Schools, Tierra Amarilla, NM 87575 Phone: 575-588-7297 Fax: 575-588-7970 |
Michele Marie Busch Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: State Road 531, Tierra Amarilla, NM 87575 Phone: 505-588-7285 |
Mrs. Sharlene Nicole Sandoval Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: St Rd 531 Bldg 1, Tierra Amarilla, NM 87575 Phone: 575-588-7297 |
News Archive
Researchers have developed a nomogram specifically for women to predict their expected exercise capacity at any given age
Researchers have developed a nomogram (alignment chart) specifically for women that can be used to predict their expected exercise capacity at any given age, as well as demonstrated that the resulting measure is a predictor of the risk of death.
Key COVID-19 information for gastroenterologists and patients with digestive conditions
A paper published today in Clinical Gastroenterology and Hepatology by clinicians at Icahn School of Medicine at Mount Sinai outlines key information gastroenterologists and patients with chronic digestive conditions need to know about COVID-19, or coronavirus.
Study provides insights into new pathways to generate universal vaccine against influenza viruses
Diverse antibodies induced in humans by vaccination with an avian influenza virus vaccine may offer broader, more durable protection against multiple strains of influenza than today's vaccines typically provide, according to a study led by Florian Krammer, PhD, Assistant Professor in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai, and Patrick Wilson, PhD, Associate Professor in the Department of Medicine at the University of Chicago.
EuroVacc 02 HIV Vaccine trial begins
The European Vaccine Effort against HIV/AIDS, has announced that a phase I clinical trial of novel investigational vaccines comprising DNA-HIV-C and NYVAC-HIV-C for the prevention of HIV infection has started in Lausanne and London in February 2005.
› Verified 2 days ago